One-stage Versus Two-stage Inverted U-shaped Ridge Splitting

January 19, 2021 updated by: Hams Hamed Abdelrahman

One-stage Versus Two-stage Inverted U-shaped Ridge Splitting With Simultaneous Implant Placement for Treatment of Anterior Maxillary Alveolar Ridge Undercut (a Comparative Randomized Clinical Trial)

Fourteen patients having anterior maxillary undercut defect were selected to match a list of inclusion and exclusion criteria.

The participants were randomly allocated using a computer system into two groups:

Group A undergo inverted U-shaped maxillary ridge splitting using piezotomes with simultaneous implant placement in the same surgery.

Group B undergo inverted U-shaped maxillary ridge splitting as a first stage and after four weeks, ridge expansion and implant placement will be performed with only envelop flap.

Assessment included measurements of bone gain at the undercut defect and bone density labial to implants in each group from the cone-beam computed tomography

Study Overview

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alexandria, Egypt
        • Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria

  • Adult patients (20-45) years of age with no sex predilection
  • At least one tooth missing in the anterior maxilla
  • The presence of a labial undercut >2 mm in thickness which is not able to house an implant
  • The presence of adequate bone width near the alveolar bone crest
  • The absence of a vertical bone defect.

Exclusion criteria

  • History of any systemic disease that would contraindicate surgery example uncontrolled diabetes.
  • Pregnancy or lactation.
  • Long-term amino-bisphosphonate therapy.
  • Smoking more than 10 cigarettes per day.
  • Alcohol or drug abuse.
  • Uncontrolled periodontal disease.
  • Active infection.
  • Inadequate inter-incisal space.
  • Bruxism or clenching.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: One stage ridge splitting

A full mucoperiosteal flap was raised using the sharp periosteal elevator to expose the bone crestally and buccally.

An inverted U-shaped bone cut, down to the cancellous bone, was done in the undercut area with a piezoelectric device.

The horizontal bone cut was made apical to the most concave point in the undercut area with a distance of 3 mm.

The two vertical bone cuts were placed at least 1 mm away from the adjacent roots and extended beyond the undercut area.

The released bone end was minimally elevated using a periosteotome through a greenstick fracture.

All implants were installed with the implant shoulders flush to the bone level using a low-speed drilling procedure.

Experimental: Two-stage ridge splitting

The first surgery is the same as one stage ridge splitting Four weeks later, after revascularization between the bone block and the mucoperiosteum, the second surgery will be performed.

A crestal incision was done and the envelope flap slightly elevated to preserve the blood supply.

The implants will be placed in the same manner as one stage ridge splitting

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in bone density buccal to the implant
Time Frame: baseline and 4 months
Bone density was evaluated by CBCT
baseline and 4 months
Change in bone width gain at the undercut area
Time Frame: baseline and 4 months
Bone width gain was evaluated by CBCT
baseline and 4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Actual)

September 30, 2020

Study Completion (Actual)

September 30, 2020

Study Registration Dates

First Submitted

January 19, 2021

First Submitted That Met QC Criteria

January 19, 2021

First Posted (Actual)

January 22, 2021

Study Record Updates

Last Update Posted (Actual)

January 22, 2021

Last Update Submitted That Met QC Criteria

January 19, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • Ridge_splitting

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Maxillary Ridge Augmentation

Clinical Trials on One stage ridge splitting with simultaneous implant placement

Subscribe